NewsSource: EClinCloud

DIA Workshop Invitation | EClinCloud Founder Dr. Qin Long to Present on Data-Driven RBQM

3 min readEClinCloud Editorial Team
640 (1).jpg

Source: EClinCloud. Author: EClinCloud.

640 (1).jpg
Click the image for the detailed agenda

April 18–19
DIA RBQM Workshop
To be held at Dawangjing Center, Beijing


Afternoon of April 19, AI Special Session

EClinCloud Founder & CEO Dr. Qin Long
Invited to give a presentation

Data-Driven RBQM:

How eCOA+EDC Improves Patient-Centric Risk Prevention and Control


We sincerely welcome you to join us!

Registration QR code
Scan the QR code to register now




Agenda

Day 1: April 18

09:00–09:45

Introduction to Basic Concepts of RBQM

Zhao Lei

General Manager, Shanghai Branch, Innovent Biologics

Vice President of Data Management / Pharmacovigilance / Clinical Quality

09:45–10:15

Application of RBQM in the Clinical Research Process

Meng Yu

Executive Director of Data Management, Innovent Biologics

10:15–10:30

Break

10:30–11:15

Key Implementation Points for RBQM-Based Project Management

Hu Ruibin

11:15–12:00

Key Application Points of RBQM in Data Management

Chen Xiaomin

MedaClin (Nanjing) Pharmaceutical Technology Co., Ltd.

Senior Manager, Data Management Department

12:00–13:00

Lunch

13:30–14:15

Statistical Support for Centralized Monitoring

Li Yasha

BeiGene, Data Science and Digital Innovation

(DSDI), Associate Director of Centralized Statistical Monitoring

14:15–15:00

Cross-Functional Collaboration in RBQM

Sun Hualong, MD

Suzhou ClinLink Pharmaceutical Technology Co., Ltd.

Chief Strategy Officer

15:00–15:15

Break

15:15–16:00

Application of RBQM Tools and Platforms

Li Yasha

BeiGene, Data Science and Digital Innovation

(DSDI), Associate Director of Centralized Statistical Monitoring

16:00–17:00

Panel Discussion: Challenges and Solutions in Cross-Functional Collaboration

Day 2: April 19

09:00–09:45

Key Points for Data Management Inspections – System Level

Wang Hongwei

Head of Global Data Management, BeiGene

Executive Director

09:45–10:15

Key Points for Data Management Inspections – Trial Level

Zhao Lei

General Manager, Shanghai Branch, Innovent Biologics

Vice President of Data Management / Pharmacovigilance / Clinical Quality

10:15–10:30

Break

10:30–11:15

On-Site Inspection Expert Presentation

Mei Ni

Senior Reviewer, Shanghai Center for Drug Evaluation

11:15–12:00

Panel Discussion: Preparation and Response for Data Management Inspections

12:00–13:00

Lunch

13:30–14:15

RBQM Case Example in Data Management (1)

Yang Qianyao

Centralized Monitoring Manager, Data Management and Centralized Monitoring, Johnson & Johnson Innovative Medicine

14:15–15:00

RBQM Case Example in Data Management (2)

Wang He

Centralized Monitoring Manager, Data Management and Centralized Monitoring, Johnson & Johnson Innovative Medicine

15:00–15:15

Break

15:15–16:15

Integrating RBQM and AI: Exploration, Scenarios, and Outlook

Data-Driven RBQM: How eCOA+EDC Improves Patient-Centric Risk Prevention and Control

Dr. Qin Long

Founder & CEO, EClinCloud

Examples of AI-Driven Data Quality Optimization and Usability Improvement in Clinical Research

Yan Dong

Product Solutions Consultant, Dassault Systèmes Medidata

AI Agent-Driven End-to-End Clinical Data Chain

Zhuang Yonglong, PhD

Founder/Chairman, Bioknow

16:15–17:00

Panel Discussion Open Conversation on the Path to AI in Data Management

The speakers above and

Sun Hualong, Wang Hongwei, Zhao Lei



Venue:
16th Floor Auditorium, Tower A, Dawangjing Center, Courtyard 2, Yuan'an South 2nd Road, Chaoyang District, Beijing

Article illustration

Scan the QR code to register now





About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it develops an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and accurate digital solutions. Relying on AI predictive models and an intelligent data platform, EClinCloud dynamically assesses and helps improve the success rate of drug clinical trials, helping shorten drug/device development cycles to benefit patients.







Article illustration


Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.